Reuters logo
BRIEF-Cadila Healthcare says Zydus gets final approval from U.S. FDA for aspirin & extended-release dipyridamole capsules
August 30, 2017 / 4:56 AM / 23 days ago

BRIEF-Cadila Healthcare says Zydus gets final approval from U.S. FDA for aspirin & extended-release dipyridamole capsules

Aug 30 (Reuters) - Cadila Healthcare Ltd:

* Says Zydus receives final approval from USFDA for aspirin and extended-release dipyridamole capsules

* Drug will be manufactured at group’s formulations manufacturing facility at Moraiya, Ahmedabad

* Drug is an antiplatelet agent which works in prevention of excessive blood clotting

Source text - bit.ly/2wmMV9D

Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below